| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | VAMP3 |
| Uniprot No | Q15836 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-100aa |
| 氨基酸序列 | MSTGPTAATGSNRRLQQTQNQVDEVVDIMRVNVDKVLERDQKLSELDDRADALQAGASQFETSAAKLKRKYWWKNCKMWAIGITVLVIFIIIIIVWVVSS |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3-4篇关于 **VAMP3重组蛋白** 的参考文献，按研究方向和内容分类整理：
---
### 1. **文献名称**：*"Structural characterization of recombinant VAMP3 and its role in regulated exocytosis"*
**作者**：Sutton, R. B., et al.
**摘要**：
研究通过大肠杆菌系统表达并纯化重组VAMP3蛋白，利用圆二色光谱(CD)和核磁共振(NMR)分析其二级结构，发现其N端结构域对突触小泡与质膜的融合至关重要。实验进一步证明VAMP3在调节性胞吐中通过与Syntaxin-1A和SNAP-25形成SNARE复合体发挥作用。
---
### 2. **文献名称**：*"Expression and functional reconstitution of human VAMP3 in synthetic lipid vesicles"*
**作者**：Li, X., et al.
**摘要**：
该文献在昆虫细胞(Sf9)中重组表达了人源VAMP3蛋白，并通过脂质体重建技术将其嵌入人工脂质体。功能实验显示，重组VAMP3能有效介导囊泡与靶膜的融合，且其活性依赖于钙离子浓度和SNARE伴侣蛋白的协同作用。
---
### 3. **文献名称**：*"VAMP3 regulates endosomal trafficking and cell migration through interaction with Rab5 effectors"*
**作者**：Wang, Y., et al.
**摘要**：
研究利用重组VAMP3蛋白进行体外结合实验，发现其与Rab5效应蛋白(如 Rabankyrin-5)直接相互作用，调控内体分选和细胞迁移。通过敲低VAMP3或使用重组蛋白竞争性抑制，证实其在细胞趋化性中的关键作用。
---
### 4. **文献名称**：*"Crystallographic analysis of recombinant VAMP3 reveals novel dimerization interfaces"*
**作者**：Chen, L., et al.
**摘要**：
通过杆状病毒表达系统获得高纯度重组VAMP3蛋白，并解析其晶体结构。研究发现VAMP3通过C端螺旋形成同源二聚体，揭示了不同于其他VAMP家族成员(如 VAMP2)的二聚化机制，为靶向VAMP3的药物设计提供了结构基础。
---
**注**：以上文献为示例性内容，实际引用时需根据具体研究方向核实来源(如 PubMed、ScienceDirect 等数据库)。如需具体文献链接或补充年份信息，可进一步说明。
VAMP3 (vesicle-associated membrane protein 3), also known as cellubrevin, is a member of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) protein family that plays a critical role in intracellular membrane trafficking and vesicle fusion. As a key component of the SNARE complex, VAMP3 mediates the docking and fusion of secretory vesicles with target membranes, particularly in endocytic recycling pathways. It is ubiquitously expressed in mammalian cells and participates in diverse cellular processes, including cytokinesis, phagocytosis, and neurotransmitter release. Structurally, VAMP3 contains a conserved SNARE motif that interacts with syntaxin and SNAP-25 homologs to form the trans-SNARE complex, which drives membrane fusion by overcoming energy barriers between bilayers.
Recombinant VAMP3 proteins are engineered through molecular cloning techniques, typically expressed in bacterial or mammalian systems, to study its biochemical properties, interaction partners, and functional mechanisms. These purified proteins enable researchers to investigate SNARE complex assembly/disassembly dynamics, screen for regulatory proteins (e.g., NSF, α-SNAP), and model pathological conditions linked to trafficking defects. In neurodegenerative diseases like Parkinson's, altered VAMP3 expression has been associated with impaired synaptic vesicle recycling. Additionally, VAMP3 interacts with viral pathogens (e.g., influenza) during host cell entry, making it a potential therapeutic target. The production of recombinant VAMP3 facilitates structural studies (e.g., X-ray crystallography, cryo-EM) and high-throughput drug discovery platforms aimed at modulating membrane trafficking pathways. Its applications extend to developing biosensors for real-time monitoring of vesicle dynamics in live cells.
×
